NewslettersHematopoiesis News Optimized BEAC Conditioning Regimen Improves Clinical Outcomes of Autologous Hematopoietic Stem Cell Transplantation in Non-Hodgkin Lymphomas By Noshin Noorjahan - April 8, 2024 0 Scientists explored the efficacy and safety of an optimized BEAC (adjusted-dose, intermediate-dose cytarabine and reduced-dose cyclophosphamide, AD-BEAC) conditioning regimen for non-Hodgkin lymphoma. [International Journal of Hematology] Full Article